Serologically Active, Clinically Stable Systemic Lupus Erythematosus
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Serologically Active, Clinically Stable Systemic Lupus Erythematosus is a clinical trial[1].
Key Facts
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus is in the country of United States[2].
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus's instance of is recorded as clinical trial[3].
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus's start time is recorded as +1997-09-30T00:00:00Z[4].
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus's end time is recorded as +2002-08-31T00:00:00Z[5].
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus's main subject is recorded as hormone therapy[6].
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus's number of participants is recorded as {'unit': '1', 'amount': '+154'}[7].
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus's title is recorded as Serologically Active, Clinically Stable Systemic Lupus Erythematosus (SLE)[8].
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus's short name is recorded as SACS-SLE[9].
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+13'}[10].
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus's ClinicalTrials.gov ID is recorded as NCT00000421[11].
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}[12].
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus's research intervention is recorded as prednisone[13].
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus's clinical trial phase is recorded as phase II clinical trial[14].
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus's research site is recorded as Lenox Hill Hospital[15].
- Serologically Active, Clinically Stable Systemic Lupus Erythematosus's study type is recorded as interventional study[16].